MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 2, 2007; DOI: 10.1124/mol.107.037044


0026-895X/07/7205-1258-1268$20.00
Mol Pharmacol 72:1258-1268, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.037044v1
mol.107.037044v2
72/5/1258    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juvin, V.
Right arrow Articles by Rassendren, F.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juvin, V.
Right arrow Articles by Rassendren, F.-A.

Pharmacological Characterization and Molecular Determinants of the Activation of Transient Receptor Potential V2 Channel Orthologs by 2-Aminoethoxydiphenyl BorateFormula

Véronique Juvin, Aubin Penna, Jean Chemin, Yea-Lih Lin, and François-A. Rassendren

Department of Molecular Pharmacology, Institut de Génomique Fonctionnelle, Montpellier, France (V.J., A.P., F-A.R.); Department of Physiology, Institut de Génomique Fonctionnelle, Montpellier, France (J.C.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Montpellier, France (V.J., A.P., J.C., F-A.R.); Institut National de la Santé etdela Recherche Médicale, U661, Montpellier, France (V.J., A.P., J.C., F.-A.R.); Université de Montpellier (IFR3), Montpellier, France (V.J., A.P., J.C., F.-A.R.); Institut de Génétique Humaine, Montpellier, France (Y.-L.L.); Centre National de la Recherche Scientifique UPR1142, Montpellier, France (Y.-L.L.)

Despite its expression in different cell types, transient receptor potential V2 (TRPV2) is still the most cryptic members of the TRPV channel family. 2-Aminoethoxydiphenyl borate (2APB) has been shown to be a common activator of TRPV1, TRPV2, and TRPV3, but 2APB-triggered TRPV2 activation remains to be thoroughly characterized. In this study, we have developed an assay based on cell lines stably expressing mouse TRPV2 channels and intracellular calcium measurements to perform a pharmacological profiling of the channel. Phenyl borate derivatives were found to activate mouse TRPV2 with similar potencies and thus were used to screen a panel of channel blockers. Besides the classic TRP inhibitors ruthenium red (RR) and 1-(beta-[3-(4-methoxyphenyl) propoxy]-4-methoxyphenethyl)-1H-imidazole hydrochloride (SKF96365), two potassium channel blockers, tetraethylammonium (TEA) and 4-aminopyridine, and an inhibitor of capacitative calcium entry, 1-(2-(trifluoromethyl) phenyl) imidazole (TRIM), were found to inhibit TRPV2 activation by 100 µM 2APB. Activation by 300 µM 2APB, however, could only be inhibited by RR and TRIM. Electrophysiological recordings demonstrated that TEA inhibition was use-dependent, suggesting that high concentrations of 2APB might induce a progressive conformational change of the channel. Comparison of TRPV2 orthologs revealed that the human channel was insensitive to 2APB. Analysis of chimeric constructs of mouse and human TRPV2 channels showed that the molecular determinants of 2APB sensitivity could be localized to the intracellular amino and carboxyl domains. Finally, using lentiviral-driven expression, we demonstrate that hTRPV2 exerts a dominant-negative effect on 2APB activation of native rodent TRPV2 channels and thus may provide an interesting tool to investigate cellular functions of TRPV2 channels.


Received April 12, 2007; accepted August 2, 2007

Address correspondence to: Dr. François-A Rassendren, Department of Molecular Pharmacology, Institut de Génomique Fonctionnelle, 141 rue de la Cardonille, 34094 Montpellier, France. Email: far{at}igh.cnrs.fr




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. L. Zhang, J. A. Kozak, W. Jiang, A. V. Yeromin, J. Chen, Y. Yu, A. Penna, W. Shen, V. Chi, and M. D. Cahalan
Store-dependent and -independent Modes Regulating Ca2+ Release-activated Ca2+ Channel Activity of Human Orai1 and Orai3
J. Biol. Chem., June 20, 2008; 283(25): 17662 - 17671.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Qin, M. P. Neeper, Y. Liu, T. L. Hutchinson, M. L. Lubin, and C. M. Flores
TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons
J. Neurosci., June 11, 2008; 28(24): 6231 - 6238.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics